Introduction:
The biologics market in India is experiencing significant growth, with the country becoming a key player in the global pharmaceutical industry. According to recent statistics, the biologics market in India is projected to reach $40 billion by 2026, driven by increasing investments in research and development. In this report, we will unveil the top 30 premier biologic companies in India in 2026.
Top 30 Premier Biologic Companies in India 2026:
1. Biocon Limited
Biocon Limited is a leading biopharmaceutical company in India, known for its innovative biologic products. With a market share of 20%, Biocon continues to expand its portfolio and strengthen its presence in the global market.
2. Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is another prominent player in the Indian biologics market, with a diverse range of biologic products. The company holds a 15% market share and has been focusing on expanding its manufacturing capabilities.
3. Serum Institute of India
Serum Institute of India is renowned for its vaccines and biologic products, holding a market share of 12%. The company’s commitment to affordability and accessibility has made it a key player in the global market.
4. Cadila Healthcare
Cadila Healthcare is a leading biopharmaceutical company in India, with a market share of 10%. The company’s focus on research and development has enabled it to launch innovative biologic products.
5. Lupin Limited
Lupin Limited is a key player in the Indian biologics market, with a market share of 8%. The company has been investing in biologic research and development to expand its product offerings.
Insights:
The biologics market in India is poised for continued growth, driven by increasing investments in research and development. By 2026, the market is projected to reach $40 billion, with biopharmaceutical companies playing a key role in driving innovation and expansion. As India emerges as a global hub for biologics, companies will need to focus on research and development to stay competitive in the market. With a strong regulatory framework and skilled workforce, India is well-positioned to become a leader in the global biologics market.
Related Analysis: View Previous Industry Report
